TY  - CONF

T1  - A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab plus ipilimumab in patients with advanced unresectable melanoma: Efficacy and safety results from the open-label phase 2 SCOPE trial

JO  - JOURNAL OF CLINICAL ONCOLOGY

PY  - 2024/01/01

AU  - Shaw HM

AU  - Patel PM

AU  - Payne M

AU  - Kumar S

AU  - Danson S

AU  - Highley M

AU  - Prasad K

AU  - Board R

AU  - Barlow C

AU  - Larkin J

AU  - Young K et al

ED  - 

VL  - 42

IS  - 16

Y2  - 2024/09/19

ER  -